Woodcock: Use Of Real-World Evidence Still Brings ‘A Lot Of Problems’
US FDA acting commissioner Janet Woodcock says the use of real-world evidence in product reviews will be slower than many of its supporters are hoping because there are a number of problems that still need to be addressed.
